Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11, Pages 2011-2019
http://dx.doi.org/10.1100/2011/671453
Review Article

The Role of CD40/CD40 Ligand Interactions in Bone Marrow Granulopoiesis

1Department of Hematology, University of Crete School of Medicine, P.O. Box 1352, 71110 Heraklion, Crete, Greece
2Graduate Program “Molecular Basis of Human Disease”, University of Crete School of Medicine, 71003 Heraklion, Greece

Received 29 August 2011; Accepted 5 October 2011

Academic Editor: Marco Antonio Cassatella

Copyright © 2011 Irene Mavroudi and Helen A. Papadaki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Schönbeck and P. Libby, “The CD40/CD154 receptor/ligand dyad,” Cellular and Molecular Life Sciences, vol. 58, no. 1, pp. 4–43, 2001. View at Google Scholar
  2. C. Van Kooten and J. Banchereau, “CD40-CD40 ligand: a multifunctional receptor-ligand pair,” Advances in Immunology, vol. 61, pp. 1–77, 1996. View at Google Scholar · View at Scopus
  3. N. Ramesh, V. Ramesh, J. F. Gusella, and R. Geha, “Chromosomal localization of the gene for human B-cell antigen CD40,” Somatic Cell and Molecular Genetics, vol. 19, no. 3, pp. 295–298, 1993. View at Google Scholar · View at Scopus
  4. M. Poggi, J. Jager, O. Paulmyer-Lacroix et al., “The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes,” Diabetologia, vol. 52, no. 6, pp. 1152–1163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. A. Bishop, C. R. Moore, P. Xie, L. L. Stunz, and Z. J. Kraus, “TRAF proteins in CD40 signaling,” Advances in Experimental Medicine and Biology, vol. 597, pp. 131–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. I. S. Grewal and R. A. Flavell, “CD40 and CD154 in cell-mediated immunity,” Annual Review of Immunology, vol. 16, pp. 111–135, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. T. M. Foy, A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle, “Immune regulation by CD40 and its ligand GP39,” Annual Review of Immunology, vol. 14, pp. 591–617, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. L. F. Lu, C. L. Ahonen, E. F. Lind et al., “The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation,” Blood, vol. 110, no. 1, pp. 193–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. L. Ahonen, E. M. Manning, L. D. Erickson et al., “The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells,” Nature Immunology, vol. 3, no. 5, pp. 451–456, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Dunn, C. J. Luedecker, H. S. Haugen, C. H. Clegg, and A. G. Farr, “Thymic overexpression of CD40 ligand disrupts normal thymic epithelial organization,” Journal of Histochemistry and Cytochemistry, vol. 45, no. 1, pp. 129–141, 1997. View at Google Scholar · View at Scopus
  11. S. J. Jenkins, G. Perona-Wright, and A. S. MacDonald, “Full development of Th2 immunity requires both innate and adaptive sources of CD154,” Journal of Immunology, vol. 180, no. 12, pp. 8083–8092, 2008. View at Google Scholar · View at Scopus
  12. A. D. Straw, A. S. MacDonald, E. Y. Denkers, and E. J. Pearce, “CD154 plays a central role in regulating dendritic cell activation during infections that induce TH1 or TH2 responses,” Journal of Immunology, vol. 170, no. 2, pp. 727–734, 2003. View at Google Scholar · View at Scopus
  13. G. Iezzi, I. Sonderegger, F. Ampenberger, N. Schmitz, B. J. Marsland, and M. Kopf, “CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 3, pp. 876–881, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. R. Alderson, R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs, “CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40,” Journal of Experimental Medicine, vol. 178, no. 2, pp. 669–674, 1993. View at Google Scholar · View at Scopus
  15. E. J. Schattner, K. B. Elkon, D. H. Yoo et al., “CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway,” Journal of Experimental Medicine, vol. 182, no. 5, pp. 1557–1565, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Afford, S. Randhawa, A. G. Eliopoulos, S. G. Hubscher, L. S. Young, and D. H. Adams, “CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection,” Journal of Experimental Medicine, vol. 189, no. 2, pp. 441–446, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Lievens, A. Zernecke, T. Seijkens et al., “Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis,” Blood, vol. 116, no. 20, pp. 4317–4327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Meers, A. Kasran, L. Boon et al., “Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cells,” Leukemia, vol. 21, no. 12, pp. 2411–2419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Peters, L. L. Stunz, and G. A. Bishop, “CD40 and autoimmunity: the dark side of a great activator,” Seminars in Immunology, vol. 21, no. 5, pp. 293–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Pyrovolaki, I. Mavroudi, P. Sidiropoulos, A. G. Eliopoulos, D. T. Boumpas, and H. A. Papadaki, “Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to fas-mediated apoptosis,” Arthritis and Rheumatism, vol. 60, no. 2, pp. 543–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Akashi, D. Traver, T. Miyamoto, and I. L. Weissman, “A clonogenic common myeloid progenitor that gives rise to all myeloid lineages,” Nature, vol. 404, no. 6774, pp. 193–197, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Zhu and S. G. Emerson, “Hematopoietic cytokines, transcription factors and lineage commitment,” Oncogene, vol. 21, no. 21, pp. 3295–3313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Shinjo, A. Takeshita, K. Ohnishi, and R. Ohno, “Granulocyte colony-stimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells,” Leukemia and Lymphoma, vol. 25, no. 1-2, pp. 37–46, 1997. View at Google Scholar · View at Scopus
  24. L. W. M. M. Terstappen, M. Safford, and M. R. Loken, “Flow cytometric analysis of human bone marrow. III. Neutrophil maturation,” Leukemia, vol. 4, no. 9, pp. 657–663, 1990. View at Google Scholar · View at Scopus
  25. R. G. Andrews, B. Torok-Storb, and I. D. Bernstein, “Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies,” Blood, vol. 62, no. 1, pp. 124–132, 1983. View at Google Scholar · View at Scopus
  26. J. D. Griffin, D. Linch, and K. Sabbath, “A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells,” Leukemia Research, vol. 8, no. 4, pp. 521–534, 1984. View at Google Scholar · View at Scopus
  27. A. C. Ward, D. M. Loeb, A. A. Soede-Bobok, I. P. Touw, and A. D. Friedman, “Regulation of granulopoiesis by transcription factors and cytokine signals,” Leukemia, vol. 14, no. 6, pp. 973–990, 2000. View at Google Scholar · View at Scopus
  28. J. A. Lekstrom-Himes, “The role of C/EBPε in the terminal stages of granulocyte differentiation,” Stem Cells, vol. 19, no. 2, pp. 125–133, 2001. View at Google Scholar · View at Scopus
  29. A. D. Friedman, “Transcriptional regulation of granulocyte and monocyte development,” Oncogene, vol. 21, no. 21, pp. 3377–3390, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Skokowa, G. Cario, M. Uenalan et al., “LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia,” Nature Medicine, vol. 12, no. 10, pp. 1191–1197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. V. C. Broudy, “Stem cell factor and hematopoiesis,” Blood, vol. 90, no. 4, pp. 1345–1364, 1997. View at Google Scholar · View at Scopus
  32. D. N. Haylock, M. J. Horsfall, T. L. Dowse et al., “Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand,” Blood, vol. 90, no. 6, pp. 2260–2272, 1997. View at Google Scholar · View at Scopus
  33. S. D. Lyman, L. James, L. Johnson et al., “Cloning of the human homologue of the murine flt3 ligand: a growth factor early hematopoietic progenitor cells,” Blood, vol. 83, no. 10, pp. 2795–2801, 1994. View at Google Scholar · View at Scopus
  34. W. L. Blalock, C. Weinstein-Oppenheimer, F. Chang et al., “Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs,” Leukemia, vol. 13, no. 8, pp. 1109–1166, 1999. View at Google Scholar · View at Scopus
  35. S. G. Emerson, Y. C. Yang, S. C. Clark, and M. W. Long, “Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities,” Journal of Clinical Investigation, vol. 82, no. 4, pp. 1282–1287, 1988. View at Google Scholar · View at Scopus
  36. F. J. Bot, L. Van Eijk, P. Schipper, B. Backx, and B. Lowenberg, “Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells,” Leukemia, vol. 4, no. 5, pp. 325–328, 1990. View at Google Scholar · View at Scopus
  37. S. Gartner and H. S. Kaplan, “Long-term culture of human bone marrow cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 8, pp. 4756–4759, 1980. View at Google Scholar · View at Scopus
  38. L. H. Coutinho, A. Will, J. Radford, R. Schiro, N. G. Testa, and T. M. Dexter, “Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture,” Blood, vol. 75, no. 11, pp. 2118–2129, 1990. View at Google Scholar · View at Scopus
  39. K. Kaushansky, V. C. Broudy, J. M. Harlan, and J. W. Adamson, “Tumor necrosis factor-γ and tumor necrosis factor-β (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo,” Journal of Immunology, vol. 141, no. 10, pp. 3410–3415, 1988. View at Google Scholar · View at Scopus
  40. M. L. Linenberger, F. W. Jacobson, L. G. Bennett, V. C. Broudy, F. H. Martin, and J. L. Abkowitz, “Stem cell factor production by human marrow stromal fibroblasts,” Experimental Hematology, vol. 23, pp. 1104–1114, 1995. View at Google Scholar
  41. J. DiPersio, P. Billing, S. Kaufman, P. Eghtesady, R. E. Williams, and J. C. Gasson, “Characterization of the human granulocyte-macrophage colony-stimulating factor receptor,” Journal of Biological Chemistry, vol. 263, no. 4, pp. 1834–1841, 1988. View at Google Scholar · View at Scopus
  42. A. W. Wognum, Y. Westerman, T. P. Visser, and G. Wagemaker, “Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets,” Blood, vol. 84, no. 3, pp. 764–774, 1994. View at Google Scholar · View at Scopus
  43. K. Tsuji and Y. Ebihara, “Expression of G-CSF receptor on myeloid progenitors,” Leukemia and Lymphoma, vol. 42, no. 6, pp. 1351–1357, 2001. View at Google Scholar · View at Scopus
  44. K. M. Zsebo, V. N. Yuschenkoff, S. Schiffer et al., “Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF,” Blood, vol. 71, no. 1, pp. 99–103, 1988. View at Google Scholar · View at Scopus
  45. H. P. Koeffler, J. Gasson, J. Ranyard, L. Souza, M. Shepard, and R. Munker, “Recombinant human TNF(α) stimulates production of granulocyte colony-stimulating factor,” Blood, vol. 70, no. 1, pp. 55–59, 1987. View at Google Scholar
  46. W. E. Fibbe, J. Van Damme, A. Billiau et al., “Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor,” Blood, vol. 71, no. 2, pp. 430–435, 1988. View at Google Scholar · View at Scopus
  47. W. Oster, A. Lindemann, R. Mertelsmann, and F. Herrmann, “Granulocyte-macrophage colony-stimulating factor (CSF) and multilineage CSF recruit human monocytes to express granulocyte CSF,” Blood, vol. 73, no. 1, pp. 64–67, 1989. View at Google Scholar · View at Scopus
  48. B. Sallerfors and T. Olofsson, “Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) secretion by adherent monocytes measured by quantitative immunoassays,” European Journal of Haematology, vol. 49, no. 4, pp. 199–207, 1992. View at Google Scholar · View at Scopus
  49. G. J. Lieschke, D. Grail, G. Hodgson et al., “Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization,” Blood, vol. 84, no. 6, pp. 1737–1746, 1994. View at Google Scholar · View at Scopus
  50. F. Liu, H. Y. Wu, R. Wesselschmidt, T. Kornaga, and D. C. Link, “Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice,” Immunity, vol. 5, no. 5, pp. 491–501, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Germeshausen, J. Skokowa, M. Ballmaier, C. Zeidler, and K. Welte, “G-CSF receptor mutations in patients with congenital neutropenia,” Current Opinion in Hematology, vol. 15, no. 4, pp. 332–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. I. N. Rich, “A role for the macrophage in normal hemopoiesis. I. Functional capacity of bone-marrow-derived macrophages to release hemopoietic growth factors,” Experimental Hematology, vol. 14, no. 8, pp. 738–745, 1986. View at Google Scholar · View at Scopus
  53. J. Y. Chan, D. J. Slamon, and S. D. Nimer, “Regulation of expression of human granulocyte/macrophage colony-stimulating factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 22, pp. 8669–8673, 1986. View at Google Scholar · View at Scopus
  54. V. C. Broudy, K. Kaushansky, J. M. Harlan, and J. W. Adamson, “Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor,” Journal of Immunology, vol. 139, no. 2, pp. 464–468, 1987. View at Google Scholar · View at Scopus
  55. D. Rennick, G. Yang, L. Gemmell, and F. Lee, “Control of hemopoiesis by a bone marrow stromal cell clone: lipopolysaccharide- and interleukin-1-inducible production of colony-stimulating factors,” Blood, vol. 69, no. 2, pp. 682–691, 1987. View at Google Scholar · View at Scopus
  56. K. Hestdal, S. E. W. Jacobson, F. W. Ruscetti, D. L. Longo, T. C. Boone, and J. R. Keller, “Increased granulopoiesis after sequential administration of transforming growth factor-β1 and granulocyte-macrophage colony-stimulating factor,” Experimental Hematology, vol. 21, no. 6, pp. 799–805, 1993. View at Google Scholar · View at Scopus
  57. G. T. Williams, C. A. Smith, E. Spooncer, T. M. Dexter, and D. R. Taylor, “Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis,” Nature, vol. 343, no. 6253, pp. 76–79, 1990. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Déchanet, C. Grosset, J. L. Taupin et al., “CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells,” Journal of Immunology, vol. 159, no. 11, pp. 5640–5647, 1997. View at Google Scholar · View at Scopus
  59. M. Stojakovic, R. Krzesz, A. H. Wagner, and M. Hecker, “CD154-stimulated GM-CSF release by vascular smooth muscle cells elicits monocyte activation—role in atherogenesis,” Journal of Molecular Medicine, vol. 85, no. 11, pp. 1229–1238, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. V. Henn, J. R. Slupsky, M. Gräfe et al., “CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells,” Nature, vol. 391, no. 6667, pp. 591–594, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Lienenlüke, T. Germann, R. A. Kroczek, and M. Hecker, “CD154 stimulation of interleukin-12 synthesis in human endothelial cells,” European Journal of Immunology, vol. 30, no. 10, pp. 2864–2870, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. D. H. Wagner, R. D. Stout, and J. Suttles, “Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis,” European Journal of Immunology, vol. 24, no. 12, pp. 3148–3154, 1994. View at Publisher · View at Google Scholar · View at Scopus
  63. M. C. Rissoan, C. Van Kooten, P. Chomarat et al., “The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium,” Clinical and Experimental Immunology, vol. 106, no. 3, pp. 481–490, 1996. View at Google Scholar · View at Scopus
  64. A. H. M. Galy and H. Spits, “CD40 is functionally expressed on human thymic epithelial cells,” Journal of Immunology, vol. 149, no. 3, pp. 775–782, 1992. View at Google Scholar · View at Scopus
  65. I. Mavroudi, V. Papadaki, K. Pyrovolaki, P. Katonis, A. G. Eliopoulos, and H. A. Papadaki, “The CD40/CD40 ligand interactions exert pleiotropic effects on bone marrow granulopoiesis,” Journal of Leukocyte Biology, vol. 89, no. 5, pp. 771–783, 2011. View at Publisher · View at Google Scholar
  66. L. S. Rusten, S. D. Lyman, O. P. Veiby, and S. E. W. Jacobsen, “The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro,” Blood, vol. 87, no. 4, pp. 1317–1325, 1996. View at Google Scholar · View at Scopus
  67. H. E. Broxmeyer, L. Lu, S. Cooper, L. Ruggieri, Z. H. Li, and S. D. Lyman, “Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells,” Experimental Hematology, vol. 23, no. 10, pp. 1121–1129, 1995. View at Google Scholar · View at Scopus
  68. A. Solanilla, J. Déchanet, A. El Andaloussi et al., “CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells,” Blood, vol. 95, no. 12, pp. 3758–3764, 2000. View at Google Scholar · View at Scopus
  69. C. A. De Graaf and D. Metcalf, “Thrombopoietin and hematopoietic stem cells,” Cell Cycle, vol. 10, no. 10, pp. 1582–1589, 2011. View at Publisher · View at Google Scholar
  70. J. P. DiSanto, J. Y. Bonnefoy, J. F. Gauchat, A. Fischer, and G. De Saint Basile, “CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM,” Nature, vol. 361, no. 6412, pp. 541–543, 1993. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Levy, T. Espanol-Boren, C. Thomas et al., “Clinical spectrum of X-linked hyper-IgM syndrome,” Journal of Pediatrics, vol. 131, no. 1 I, pp. 47–54, 1997. View at Publisher · View at Google Scholar · View at Scopus
  72. R. C. Allen, R. J. Armitage, M. E. Conley et al., “CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome,” Science, vol. 259, no. 5097, pp. 990–993, 1993. View at Google Scholar · View at Scopus
  73. W. C. Wang, J. Cordoba, A. J. Infante, and M. E. Conley, “Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor,” American Journal of Pediatric Hematology/Oncology, vol. 16, no. 2, pp. 160–163, 1994. View at Google Scholar · View at Scopus
  74. M. Mori, S. Nonoyama, M. Neubauer, T. Mitsuda, T. Kosuge, and S. Yokota, “Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia,” Journal of Pediatric Hematology/Oncology, vol. 22, no. 3, pp. 288–289, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. H. A. Papadaki, J. Palmblad, and G. D. Eliopoulos, “Non-immune chronic idiopathic neutropenia of adult: an overview,” European Journal of Haematology, vol. 67, no. 1, pp. 35–44, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. H. A. Papadaki, A. G. Eliopoulos, T. Kosteas et al., “Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells,” Blood, vol. 101, no. 7, pp. 2591–2600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. H. A. Papadaki, K. Stamatopoulos, A. Damianaki et al., “Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia,” British Journal of Haematology, vol. 128, no. 6, pp. 863–876, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Spanoudakis, H. Koutala, M. Ximeri, K. Pyrovolaki, K. Stamatopoulos, and H. A. Papadaki, “T-cell receptor Vβ repertoire analysis in patients with chronic idiopathic neutropenia demonstrates the presence of aberrant T-cell expansions,” Clinical Immunology, vol. 137, no. 3, pp. 384–395, 2010. View at Publisher · View at Google Scholar · View at Scopus